secwatch.observer — SEC 8-K summary
======================================

Issuer:     MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK:        0001157601
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0001193125-24-170634
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Madrigal shareholders approve 750K share increase to stock plan, extend to 2035
-------------------------------------------------------------------------------

- Stockholders approved amendment to 2015 Stock Plan, increasing share reserve by 750,000 shares.
- Plan extended through 2035; clawback policy and one-year minimum vesting requirement added.
- All three Class II director nominees (Sibold, Taub, Craves) elected with over 95% support.
- PricewaterhouseCoopers ratified as independent auditor for FY2024 with 99.4% of votes cast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157601/000119312524170634/0001193125-24-170634-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157601/000119312524170634/d839852d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-170634

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer